Article Details
Retrieved on: 2024-06-17 20:42:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Funds from the BARDA award will be used to conduct a 10,000-subject Phase 2b comparative study evaluating Vaxart's oral pill COVID-19 vaccine ...
Article found on: investors.vaxart.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here